AlphaCentric Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-80,000
Closed -$1.14M 278
2024
Q3
$1.14M Buy
+80,000
New +$1.14M 0.85% 41
2021
Q3
Sell
-2,200
Closed -$37K 217
2021
Q2
$37K Hold
2,200
0.01% 204
2021
Q1
$40K Hold
2,200
0.01% 201
2020
Q4
$40K Hold
2,200
0.02% 190
2020
Q3
$39K Hold
2,200
0.02% 121
2020
Q2
$39K Buy
+2,200
New +$39K 0.02% 96